Antibody drug for prevention or treatment of autoimmune diseases
US-2024352108-A1 · Oct 24, 2024 · US
US9012154B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9012154-B2 |
| Application number | US-201013377121-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 9, 2010 |
| Priority date | Jun 10, 2009 |
| Publication date | Apr 21, 2015 |
| Grant date | Apr 21, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to methods for detecting Ficolin-3 dependent activation of the lectin pathway of complement, methods for identifying abnormalities in Ficolin-3, and methods for screening for deficiencies/and or identifying abnormalities in any downstream components of the Ficolin-3 dependent activation of the lectin pathway of 5 complement using an acetylated Ficolin-3 ligand, said methods generally comprising the steps of: (a) providing a sample of blood, serum, plasma, another body fluid or an extract thereof; (b) (optionally) preventing in the sample activation of the classical pathway and/or the alternative pathway and/or any non-Ficolin-3 mediated activation of the lectin pathway; (c) acetylating a molecule; (d) contacting said acetylated molecule 10 with said sample, in conditions that permit specific binding of Ficolin-3 to said acetylated molecule, and, (e) detecting and quantifying specific binding of the Ficolin-3 to said acetylated molecule, (f) determining in the sample complement activation and/or deposition by the detection of a C2, C3, C4 and/or a C5 cleavage product and/or by detecting any of the terminal complement complex components C6, C7, C8 or C9 or 15 the C5b-9 terminal complement complex as such. The present invention also provides assays and kits comprising the methods of the invention.
Opening claim text (preview).
The invention claimed is: 1. A method for detecting Ficolin-3 binding to a Ficolin-3 ligand, the method comprising: detecting a complex of Ficolin-3 and a Ficolin-3 ligand, wherein the Ficolin-3 ligand is an acetylated protein that is immobilized on a support. 2. The method according to claim 1 , wherein detecting a complex of Ficolin-3 and a Ficolin-3 ligand comprises: contacting the Ficolin-3 ligand with a sample of blood, serum, plasma, another body flui…
Physics · mapped topic
Physics · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.